Clinical Trials Directory

Trials / Completed

CompletedNCT04452266

Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome

Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome: Study Conducted in the Hauts-de-France

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
Female
Age
30 Years
Healthy volunteers
Accepted

Summary

Lynch Syndrome increases Endometrial Cancer Occurrence in women due to failure in MisMatch Repair System. Lifetime Cumulative risk of developing endometrial Cancer is approximatively 40% in women with Lynch Syndrome. Endometrial cancer is the third women cancer in France. Many risk factors are known in general population. Lots of factors are related to over exposure to estrogen. Data about influence of general risk factors in Women with Lynch Syndrome are poor. Recently, a cohort study appears to have shown a significant decrease in the risk of endometrial cancer with multiparity, the use of hormonal contraception and late menopause in Lynch women. The impact of weight and certain metabolic parameters on the occurrence of endometrial cancers remains poorly known to this day.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaire assesmentEach patient will to answer questions about their medical history.

Timeline

Start date
2020-08-14
Primary completion
2020-10-20
Completion
2020-10-20
First posted
2020-06-30
Last updated
2021-03-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04452266. Inclusion in this directory is not an endorsement.